Install
Your go-to source for the latest news in health, science and medicine. Sign up for STAT+ for exclusive analysis of biotech, pharma, and the life sciences.
- 203articles · 30d
- 9+ hour agolatest article
- Aug 16, 2026earliest in window
- 95%with images
- 246avg words
- Medical 150
- Health & Wellness 138
- Health 100
- Science & Technology 46
- Business & Industrial 37
- Economy, Business & Finance 22
- Politics 19
- Politics2 18
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Trump's secretive pharma deals may undermine 'most-favored nation' pricing, an analysis suggests
9+ hour, 51+ min ago (270+ words) Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for more than three decades. His stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is…...
Medicaid will let states use ‘tiers’ to determine medical frailty
2+ day, 16+ hour ago (529+ words) WASHINGTON — The Centers for Medicare and Medicaid Services this week released guidance for states allowing them to use a “tier system” to determine which Medicaid recipients are too ill to work or volunteer at least 20 hours per week. The decision,…...
Breast cancer pill from AstraZeneca misses mark in pivotal trial
2+ day, 1+ hour ago (204+ words) STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories…...
Why two promising heart drugs flopped and what's next
3+ day, 14+ hour ago (222+ words) By Adam Feuerstein, Elaine Chen, and Allison DeAngelis On this week’s episode of “The Readout LOUD”: The pharma industry invested billions of dollars to develop drugs heralded as the next era in the treatment of heart disease — but why did…...
Up and down the ladder: The latest comings and goings
2+ day, 15+ hour ago (201+ words) Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for more than three decades. His stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is…...
Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field
3+ day, 8+ hour ago (159+ words) The back-to-back failures of cardiovascular drugs from Novartis and Novo Nordisk made headlines earlier this month. They could also have a chilling effect across the industry. Just before Labor Day, Novartis reported that its cardiac therapy, pelacarsen, failed in a…...
FDA expands Bayer lung cancer drug approval
3+ day, 18+ hour ago (183+ words) Today, we look at how regulators are trying to keep pace with agentic medical AI, see the FDA launch a project to examine why pregnancy registries struggle with enrollment, and more. Someone out there cure asthma, eh? It sucks. John…...
Roivant is one of the savviest dealmakers in biotech. It also has a secret weapon
3+ day, 21+ hour ago (208+ words) Adam Feuerstein is a senior writer and biotech columnist for STAT, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a cohost of STAT's weekly "The Readout LOUD" podcast and the author of the…...
ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure
4+ day, 16+ hour ago (211+ words) STAT ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure Program aims to create ‘autonomous prescribing cardiologists’ that plug gaps in care Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare…...
Pharmalittle: We're reading about an AstraZeneca COPD win, the FDA filling key jobs, and more
4+ day, 19+ hour ago (167+ words) Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter. FDA names acting heads of drug and vaccine…...